Published in Neurology on April 24, 2007
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45
Acute seizures in acute ischemic stroke: does thrombolysis have a role to play? J Neurol (2012) 1.03
Combined contrast-enhanced ultrasound and rt-PA treatment is safe and improves impaired microcirculation after reperfusion of middle cerebral artery occlusion. J Cereb Blood Flow Metab (2010) 0.87
Tissue at risk in the deep middle cerebral artery territory is critical to stroke outcome. Neuroradiology (2011) 0.87
Lesion patterns in successful and failed thrombolysis in middle cerebral artery stroke. Neuroradiology (2009) 0.84
Reperfusion therapies for acute ischemic stroke: an update. Curr Cardiol Rev (2014) 0.79
Endovascular therapy in hyperacute ischaemic stroke: history and current status. Interv Neuroradiol (2013) 0.76
Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban. Neurol Int (2012) 0.75
Reperfusion Beyond 6 Hours Reduces Infarct Probability in Moderately Ischemic Brain Tissue. Stroke (2015) 0.75
Re: Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology (2008) 0.75
Introduction of a new model for time-continuous and non-contact investigations of in-vitro thrombolysis under physiological flow conditions. BMC Neurol (2011) 0.75
Better late than never?: the story of arterial recanalization in acute ischemic stroke. Neurology (2007) 0.75
Late recanalisation beyond 24 hours is associated with worse outcome: an observational study. Eur Radiol (2016) 0.75
Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med (2001) 7.46
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med (2011) 5.19
K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev (1997) 4.24
Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity (1999) 3.69
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Mouse models of tumor development in neurofibromatosis type 1. Science (1999) 3.40
Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol (1996) 2.94
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke (2001) 2.45
Evaluation of an enzyme immunoassay for the diagnosis of chlamydial infections in urogenital specimens. J Clin Microbiol (1986) 2.44
Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol (1996) 2.42
Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam. Br J Vener Dis (1974) 2.31
Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1991) 2.21
Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol (2001) 2.20
Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol (1990) 2.04
Detection of Neisseria gonorrhoeae antigen by a solid-phase enzyme immunoassay. Br J Vener Dis (1982) 1.94
The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol (1993) 1.92
Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur J Immunol (1993) 1.90
[A penicillinase forming strain of gonococcus isolated in Rotterdam]. Ned Tijdschr Geneeskd (1977) 1.89
Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. Br J Vener Dis (1979) 1.87
Activity of eight antimicrobial agents in vitro against N. Gonorrhoeae. Br J Vener Dis (1975) 1.84
Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77
S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke (1997) 1.76
Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol (1989) 1.72
Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A (1995) 1.71
Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J (2004) 1.69
Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol (1995) 1.68
IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol (1998) 1.62
[Turning white overnight, is it possible?]. Ned Tijdschr Geneeskd (1993) 1.61
Antibiotic sensitivities of gonococci isolated in Rotterdam and results of treatment with cefuroxime. Br J Vener Dis (1980) 1.60
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
Crystal structure of Escherichia coli methionyl-tRNA synthetase highlights species-specific features. J Mol Biol (1999) 1.57
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med (2000) 1.57
Comparison of HeLa 229 and McCoy cell cultures for detection of Chlamydia trachomatis in clinical specimens. J Clin Microbiol (1989) 1.56
Gonorrhea in Rotterdam caused by penicillinase-producing gonococci. Br J Vener Dis (1980) 1.55
Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology (1999) 1.54
The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med (1993) 1.53
Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med (2001) 1.52
Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother (1987) 1.47
Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1993) 1.47
IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol (2001) 1.46
Non-von Recklinghausen's neurofibromatosis resembling a giant pigmented nevus. J Am Acad Dermatol (1989) 1.44
[Gentamicin skin ointment: 200 kilos too much]. Ned Tijdschr Geneeskd (1995) 1.40
[Number of admissions for Reiter's disease (ICD-9-code 099.3) in Dutch hospitals in 1981-1987]. Ned Tijdschr Geneeskd (1993) 1.39
[Marked decrease in the number of hospitalizations for gonococcal infections in The Netherlands from 1981-1988]. Ned Tijdschr Geneeskd (1993) 1.39
[Imaging of non-traumatic and non-tumoral cord lesions]. J Radiol (2010) 1.38
Gonococcal oro- and nasopharyngeal infection. Br J Vener Dis (1974) 1.37
Evaluation of the direct fluorescent antibody test for diagnosis of chlamydial infections. Eur J Clin Microbiol (1985) 1.35
Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis (2009) 1.34
IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol (1998) 1.32
Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke (1999) 1.32
Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology (1996) 1.32
In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol (2000) 1.29
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat (2008) 1.27
Heat shock proteins: endogenous modulators of apoptotic cell death. Handb Exp Pharmacol (2006) 1.27
Enzyme linked immunosorbent assays with Treponema pallidum or axial filament of T phagedenis biotype Reiter as antigen: evaluation as screening tests for syphilis. Genitourin Med (1986) 1.24
A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea. J Antimicrob Chemother (1984) 1.22
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. J Antimicrob Chemother (1984) 1.22
A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int Immunol (1996) 1.21
Primary and secondary syphilis: a histopathological study. Int J STD AIDS (1991) 1.20
Sensitivity and specificity of an enzyme-linked immunosorbent assay using the recombinant DNA-derived Treponema pallidum protein TmpA for serodiagnosis of syphilis and the potential use of TmpA for assessing the effect of antibiotic therapy. J Clin Microbiol (1989) 1.20
Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol (2006) 1.19
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res (1993) 1.19
Structure of crystalline D-Tyr-tRNA(Tyr) deacylase. A representative of a new class of tRNA-dependent hydrolases. J Biol Chem (2001) 1.18
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol (1986) 1.16
Expression of interleukin 10 in human melanoma. Br J Cancer (1994) 1.15
Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J Immunol (1989) 1.15
Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol (2006) 1.15
Influence of volume of sample processed on detection of Chlamydia trachomatis in urogenital samples by PCR. J Clin Microbiol (1995) 1.15
Mycoplasma fermentans-derived high-molecular-weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes. Infect Immun (1990) 1.14
Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol (1999) 1.13
Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol (1999) 1.13
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult Scler (2013) 1.12
Lymphangiectases of the vulva in a patient with lymph node tuberculosis. Int J Dermatol (1979) 1.09
Infections with non-penicillinase-producing Neisseria gonorrhoeae treated with cefuroxime: treatment failures. Sex Transm Dis (1987) 1.08
Comparison of cardiolipin and treponemal tests in the serodiagnosis of yaws. Br J Vener Dis (1979) 1.08
Structural and biochemical characterization of the Escherichia coli argE gene product. J Bacteriol (1992) 1.08
Enhancement of yield of Chlamydia trachomatis Hela 229 cell culture. Eur J Clin Microbiol Infect Dis (1988) 1.07
Solid-phase enzyme immunoassay for detection of Chlamydia trachomatis. Eur J Clin Microbiol (1985) 1.06
Intracellular cyclic AMP production enhanced by a hormone receptor transferred from a different cell. beta-adrenergic responses in cultured cells conferred by fusion with turkey erythrocytes. J Biol Chem (1978) 1.06
Recanalization of acute symptomatic occlusions of the internal carotid artery. J Neurol (2002) 1.06
The many routes of bacterial transfer RNAs after aminoacylation. Curr Opin Struct Biol (2000) 1.05
Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol (1986) 1.05
A patient with primary syphilis of the hand. Br J Vener Dis (1977) 1.05
Yaws in West Sumatra, Indonesia: clinical manifestations, serological findings and characterisation of new Treponema isolates by DNA probes. Eur J Clin Microbiol Infect Dis (1991) 1.05
Methionyl-tRNA synthetase from Bacillus stearothermophilus: structural and functional identities with the Escherichia coli enzyme. Nucleic Acids Res (1991) 1.05
Different response of TH1 cells for stimulation with anti-CD3 antibodies. Eur J Immunol (1990) 1.05
Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol (2000) 1.04
Autonomic nervous system function in Huntington's disease. J Neurol Neurosurg Psychiatry (2002) 1.04
Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urogenital specimens. Int J STD AIDS (1990) 1.04
A simple system of checks and balances to cut fraud. Nature (2006) 1.04
Schwannomas of the orbit. Acta Neurochir (Wien) (1980) 1.03
Different accessory function for TH1 cells of bone marrow derived macrophages cultured in granulocyte macrophage colony stimulating factor or macrophage colony stimulating factor. Int Immunol (1992) 1.03
Treatment of lymphogranuloma venereum with rifampicin. Br J Vener Dis (1979) 1.03
Gonococcal serology. A comparison of three different tests. Br J Vener Dis (1983) 1.03
A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws. J Clin Microbiol (1990) 1.03